News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Earnings
Aceto Corporation Schedules Fourth Quarter & Fiscal 2014 Financial Results News Release and Conference Call 8/22/2014
Cellectar Biosciences  (NVLT) Reports Second Quarter 2014 Financial Results And Recent Highlights 8/21/2014
Ablynx (ABLYF) Will Announce Its Half-Year Results For 2014 With Webcast 8/21/2014
China Cord Blood Corporation To Report First Quarter Of Fiscal 2015 Financial Results 8/21/2014
Medivir AB (MVRBF): Interim Report, January – June 2014* 8/21/2014
DiaGenic ASA: Q2 2014 - Financial Report 8/21/2014
Karolinska Development AB (publ) – Interim Report January – June 2014 8/21/2014
MDxHealth, Inc. (MXDHF) Reports First Half Year 2014 Results 8/21/2014
Skyepharma PLC (SKYEF) Interim Results Statement 8/21/2014
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 8 September 2014 8/21/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Third Quarter Fiscal Year 2014 8/20/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Jun. 2014 8/20/2014
Hikma Pharmaceuticals Delivers Excellent First Half Results With 16% Revenue Growth And 44% Increase In Adjusted EPS 8/20/2014
Source BioScience Release: Half Year Report For The Six Months Ended 30 June 2014 8/20/2014
Cellectar Biosciences  (NVLT) To Host Conference Call On August 20th To Discuss Second Quarter 2014 Results And Provide Quarterly Update On Development Progress 8/19/2014
PDL BioPharma, Inc. (PDLI) Announces Second Quarter 2014 And Year To Date Financial Results 8/19/2014
Probi: Highest-Ever Net Sales For A Single Quarter 8/19/2014
Notice Of Zealand Pharma  (ZEAL.CO)'s Interim Report For H1 2014 And Related Conference Call 8/18/2014
Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2014 Operational and Financial Results 8/18/2014
PDL BioPharma, Inc. (PDLI) Announces Plans To Issue Second Quarter Financial Results After Market Today And Reschedules Earnings Call For Tuesday, August 19 At 4:30pm EDT 8/18/2014
GlobeImmune, Inc. (GBIM) Announces Second Quarter 2014 Financial Results 8/18/2014
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Third Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 8/18/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The First Quarter Of Fiscal Year 2015 8/15/2014
ZS Pharma (ZSPH) Announces Second Quarter 2014 Financial Results 8/15/2014
Aurinia (ISA.TO) Reports Second Quarter 2014 Financial Results 8/15/2014
Arno Therapeutics Reports Second Quarter 2014 Financial And Business Update 8/15/2014
Kite Pharma, Inc. Reports Second Quarter 2014 Results 8/15/2014
Opexa Therapeutics (OPXA) Reports Second Quarter 2014 Financial Results And Provides Corporate Update 8/15/2014
RestorGenex Reports Second Quarter 2014 Financial Results 8/15/2014
Agilent Technologies Inc. (A) Reports Third-Quarter 2014 Results 8/15/2014
La Jolla Pharmaceutical Company (LJPC) Announces Second Quarter And Year-To-Date 2014 Financial Results 8/15/2014
Targeted Medical Pharma Reports Second Quarter 2014 Financial Results 8/15/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Second Quarter Financial Results 8/15/2014
Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results 8/15/2014
Ruthigen Reports Fiscal First Quarter 2015 Financial Results 8/15/2014
Intrexon Corporation Announces Second Quarter And First Half 2014 Financial Results 8/15/2014
Dyadic International, Inc. Reports Q2 2014 Financial Results 8/15/2014
Nephros Inc. (NEP) Reports Second Quarter 2014 Financial Results 8/15/2014
Echo Therapeutics (ECTE) Announces Second Quarter 2014 Financial Results and Provides Business Update 8/14/2014
Heat Biologics Reports 2014 Second Quarter Financial Results 8/14/2014
Stemline Therapeutics, Inc. (STML) Provides Second Quarter 2014 Financial Results And Corporate Update 8/14/2014
Aastrom Biosciences, Inc. (ASTM) Reports Second Quarter 2014 Financial Results 8/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For Quarter Ended June 30, 2014 8/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Second Quarter 2014 Financial Results 8/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Second Quarter 2014 Financial Results 8/14/2014
Cellular Biomedicine Group (CBMG) Reports Second Quarter And First Half 2014 Financial Results And Provides Business Highlights 8/14/2014
Perrigo Company (PRGO) Announces Quarterly Dividend 8/14/2014
Interleukin Genetics Inc. (ILGN) Reports Second Quarter 2014 Financial Results 8/14/2014
Kindred Bio (KIN) Announces Second Quarter 2014 Financial Results 8/14/2014
SAGE Therapeutics Reports Second Quarter 2014 Financial Results 8/14/2014
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014
22nd Century Group, Inc. Reports Second Quarter 2014 Financial Results 8/14/2014
Veracyte, Inc. (VCYT) Announces Second Quarter 2014 Financial Results 8/14/2014
Rexahn Pharmaceuticals, Inc. (RNN) Reports Second Quarter 2014 Financial Results And Pipeline Update 8/14/2014
BASi (BASI) Reports Third Quarter Net Income Of $.03 Per Share 8/14/2014
PDI, Inc. (PDII) Reports 2014 Second Quarter Financial Results 8/14/2014
WuXi PharmaTech Co., Ltd. Announces Second-Quarter 2014 Results 8/14/2014
Imprimis Pharmaceuticals (immy) Announces Second Quarter 2014 Financial Results And Provides Operational Update 8/14/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January – June 2014 8/14/2014
Recipharm AB: Interim Report January-June 2014 8/14/2014
InSite Vision (ISV) Reports Second Quarter 2014 Financial Results 8/14/2014
Concordia Healthcare Corp (CXR.TO) Announces Financial And Operational Results For Its Second Quarter, Ended June 30, 2014 8/14/2014
DATATRAK International, Inc. (DATA) Reports Second Quarter Results Of 2014 8/14/2014
Concord Medical Services Holdings Limited (CCM) Reports Second Quarter 2014 Financial Results 8/14/2014
Synthetic Biologics, Inc. (SYN) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/14/2014
CASI Pharmaceuticals  (ENMD) Reports Second Quarter 2014 Financial Results 8/14/2014
RXi Pharmaceuticals (RXII) Reports Financial Results For The Second Quarter Of 2014 8/14/2014
Perrigo Company (PRGO) Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins 8/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Second Quarter 2014 Financial Results 8/14/2014
VWR International, Inc. To Hold Second Quarter 2014 Financial Results Conference Call 8/14/2014
Cord Blood America, Inc. Announces 2014 Second Quarter Financial Results 8/14/2014
RBC Life Sciences, Inc. Reports Second Quarter Results 8/14/2014
HEALTHSOUTH To Present At The Baird 2014 Healthcare Conference 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Inergetics, Inc.: 2014 Second Quarter Earnings Announcement 8/14/2014
Microbix Biosystems Inc. (MBXBF)’ Virology Revenue Grows 24% In Third Quarter, Company Reports Fourth Consecutive Quarterly Profit 8/14/2014
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On August 18, 2014 8/13/2014
Anavex Life Sciences Corp. (AVXL.OB) Reports Fiscal Third Quarter 2014 Financial Results 8/13/2014
SCYNEXIS, Inc. (SCYX) Reports Second Quarter 2014 Financial Results 8/13/2014
Epizyme (EPZM) Announces Second Quarter 2014 Financial Results And Provides Corporate Update 8/13/2014
Eleven Biotherapeutics (EBIO) Reports Second Quarter 2014 Financial Results 8/13/2014
TetraPhase Pharmaceuticals Reports Second-Quarter 2014 Financial Results 8/13/2014
bluebird bio (BLUE) Reports Fiscal Second Quarter 2014 Financial Results 8/13/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Third Quarter Financial Results And Provides Update On ARC-520 8/13/2014
Ignyta (RXDX) Announces Second Quarter 2014 Company Highlights And Financial Results 8/13/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - June 2014 8/13/2014
Ambit Biosciences Announces Second Quarter 2014 Operating Results 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Capricor Therapeutics, Inc. Reports Second Quarter 2014 Financial & Business Highlights 8/13/2014
Tengion Inc. Provides Clinical Update And Reports Second Quarter 2014 Financial Results 8/13/2014
Emisphere Technologies, Inc. (EMIS) Announces Second Quarter 2014 Earnings Conference Call 8/13/2014
Kindred Bio (KIN) Announces Second Quarter 2014 Financial Results 8/13/2014
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Second Quarter Of 2014 8/13/2014
Conatus Pharmaceuticals Inc. Reports Second Quarter 2014 Financial Results And Program Updates 8/13/2014
Onconova Therapeutics Inc. (ONTX) Reports Second Quarter 2014 Financial And Operational Results 8/13/2014
Evoke Pharma, Inc. Reports Second Quarter 2014 Results 8/13/2014
Argos Therapeutics, Inc. (ARGS) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/13/2014
Zafgen (ZFGN) Reports Second Quarter 2014 Financial Results 8/13/2014
Tekmira Pharmaceuticals Corporation (TKMR) Provides Corporate Update And Announces Second Quarter 2014 Results 8/13/2014
Epigenomics AG Announces H1 2014 And Q2 2014 Financial Results And Reports On Operational Highlights 8/12/2014
Dipexium Pharmaceuticals (DPRX) Reports Second Quarter 2014 Financial and Operational Results 8/12/2014
CytoSorbents, Inc. Records Another Solid Quarter Of Growth In Q2 2014 8/12/2014
Fate Therapeutics (FATE) Reports Second Quarter 2014 Financial Results 8/12/2014
StemCells Inc. (STEM) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Reports Revenues Of $49.0 Million For The Second Quarter Ended June 30, 2014 8/12/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Second Quarter 2014 Financial Results 8/12/2014
ReVance Therapeutics, Inc. (RVNC) Releases Second Quarter 2014 Financial Results 8/12/2014
Cerulean Pharma Inc. (CERU) Reports Second Quarter 2014 Corporate Highlights And Financial Results 8/12/2014
Corium International, Inc. Reports Third Fiscal Quarter 2014 Financial Results 8/12/2014
Ocera Therapeutics, Inc. (OCRX) Reports Second Quarter 2014 Financial Results 8/12/2014
Relypsa, Inc. (RLYP) Announces Second Quarter 2014 Financial Results 8/12/2014
Intercept Pharmaceuticals (ICPT) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Achaogen (AKAO) Announces Second Quarter 2014 Results 8/12/2014
Aquinox Pharmaceuticals (AQXP) Announces Second Quarter 2014 Financial Results 8/12/2014
Galena Biopharma  (GALE) Reports Second Quarter 2014 Results 8/12/2014
Supernus Pharmaceuticals (SUPN) Announces Second Quarter 2014 Results 8/12/2014
Cellular Dynamics International International Reports Second Quarter 2014 Financial Results 8/12/2014
Athersys, Inc. (ATHX) Reports Second Quarter 2014 Results 8/12/2014
Apricus Biosciences (APRI) Provides Corporate Update And Second Quarter 2014 Financial Results 8/12/2014
Evotec AG (EVTG.F) Reports Results Of First Half Of 2014 8/12/2014
Recro Pharma (REPH) Reports Second Quarter 2014 Financial Results 8/12/2014
Akers Biosciences, Inc. Reports Its Second Quarter Financial Results 8/12/2014
ProSensa Holding N.V. (RNA) Announces 2nd Quarter 2014 Financial Results And Recent Corporate Developments 8/12/2014
Intra-Cellular Therapies, Inc. Reports Financial Results For Second Quarter Ended June 30, 2014 8/12/2014
Receptos (RCPT) Reports Second Quarter 2014 Financial Results 8/12/2014
Radius (RDUS) Reports Second Quarter 2014 Financial And Operating Results 8/12/2014
Aurinia (ISA.TO) To Present At The Canaccord Genuity 34th Annual Growth Conference 8/12/2014
Synergy Pharmaceuticals Reports Second Quarter And First Half 2014 Financial Results 8/12/2014
Opko Health, Inc. Announces Second Quarter Operating And Financial Results 8/12/2014
AcelRx Pharmaceuticals (ACRX) Reports Second Quarter 2014 Financial Results 8/12/2014
ADMA Biologics, Inc. Reports Second Quarter 2014 Financial And Operational Results 8/12/2014
NephroGenex (NRX) Reports Second Quarter 2014 Financial Results 8/12/2014
BioSpecifics Technologies Corporation (BSTC) Reports Second Quarter 2014 Financial Results 8/12/2014
AVEO Oncology (AVEO) Reports Second Quarter 2014 Financial Results And Updates Progress On Strategic Plan 8/12/2014
Puma Biotechnology (PBYI) Reports Second Quarter 2014 Financial Results 8/12/2014
Omeros Corporation (OMER) Reports Second Quarter 2014 Financial Results 8/12/2014
Cytori Therapeutics, Inc. (CYTX) Reports Second Quarter 2014 Business And Financial Results 8/12/2014
Oncothyreon Inc. (ONTY) Reports Second Quarter 2014 Financial Results 8/12/2014
Acceleron Pharma Reports Second Quarter 2014 Financial Results 8/12/2014
Retrophin, Inc. (RTRX) Reports Second Quarter 2014 Financial Results 8/12/2014
Halozyme Therapeutics, Inc. (HALO) Reports Second Quarter 2014 Financial Results 8/12/2014
Taxus Cardium (CRXM) Presents Second Quarter 2014 Financial Results And Recent Developments 8/12/2014
Rock Creek Pharmaceuticals Reports Second Quarter And Announces Clinical Update 8/12/2014
BioTime (BTX) Announces Second Quarter 2014 Results And Recent Developments 8/12/2014
Idera Pharmaceuticals, Inc. (IDRA) Reports Second Quarter 2014 Financial Results And Provides Corporate Update 8/12/2014
Concert Pharmaceuticals, Inc. (CNCE) Reports Second Quarter 2014 Financial Results And Provides Company Update 8/12/2014
Trevena, Inc. (TRVN) Reports Second Quarter 2014 Financial Results 8/12/2014
Regado Biosciences, Inc. (RGDO) Announces Second Quarter 2014 Financial Results And Corporate Highlights 8/12/2014
Egalet Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Aratana Therapeutics (PETX) Reports Second Quarter 2014 Results 8/12/2014
Array BioPharma, Inc. (ARRY) Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 8/12/2014
GenVec Inc. (GNVC) Reports Second Quarter 2014 Financial Results 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
ChromaDex, Inc. Reports Second Quarter Ingredient Sales Grew 155% Year-Over-Year And 52% Sequentially 8/12/2014
Intrexon Corporation To Announce First Half And Second Quarter 2014 Results And Host Conference Call On August 14th 8/12/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Reports Financial Results For The Three And Six Months Ended June 30, 2014 8/12/2014
Delcath Systems, Inc. (DCTH) Losses Reach $11.4 Million For The First Half Of 2014 8/11/2014
Merrimack Pharmaceuticals Inc. (MACK) Reports Second Quarter 2014 Financial Results 8/11/2014
Repligen Corporation (RGEN) Reports Second Quarter 2014 Financial Results 8/11/2014
Alcobra (ADHD) Announces Second Quarter Financial Results And Provides Corporate Update 8/11/2014
Hemispherx Biopharma (HEB) Announces Financial Results For The Six Months Ended June 30, 2014 8/11/2014
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2014 Financial Results 8/11/2014
MannKind Corporation (MNKD) Reports 2014 Second Quarter Financial Results 8/11/2014
Ultragenyx Pharmaceuticals (RARE) Reports Second Quarter 2014 Financial Results And Corporate Update 8/11/2014
Repros Therapeutics Inc. (RPRX) Reports Second Quarter 2014 Financial Results 8/11/2014
Nymox Pharmaceutical (NYMX) Reports Second Quarter 2014 Financial Results 8/11/2014
Aastrom Biosciences, Inc. (ASTM) To Host Second Quarter 2014 Earnings Call On August 14, 2014 8/11/2014
Coronado Biosciences (CNDO) Reports Financial Results 8/11/2014
PDI, Inc. (PDII) To Hold Second Quarter Financial Results Conference Call On Thursday, August 14, 2014 8/11/2014
Akebia Therapeutics, Inc. (AKBA) Announces Second Quarter 2014 Financial Results 8/11/2014
Bio-Techne Releases Fourth Quarter And Full Year 2014 Results 8/11/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Third Quarter Ended June 30, 2014 8/11/2014
Eagle Pharmaceuticals (EGRX) Reports Third Quarter 2014 Results 8/11/2014
Fibrocell Science, Inc. Reports Second Quarter And First Half 2014 Financial And Operating Results 8/11/2014
Opexa Pharmaceuticals, Inc. Announces News Release And Conference Call Schedule To Discuss Second Quarter 2014 Financial Results 8/11/2014
Cardiome Pharma Corp. (COM.TO) Reports Second Quarter 2014 Financial Results 8/11/2014
Soligenix (SNGX) Reports Second Quarter 2014 Financial Results, And Highlights Recent Accomplishments 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
CEL-SCI (CVM) Reports Third Quarter Fiscal 2014 Financial Results 8/11/2014
Invitation To Presentation Of Recipharm AB’s Interim Report For The Second Quarter Of 2014 On August 14th 8/11/2014
Pernix Therapeutics, Inc. (PTX) Reports Second Quarter 2014 Financial Results 8/11/2014
Chindex International, Inc. (CHDX) Reports Financial Results For Second Quarter And First Half Of 2014 8/11/2014
Inovio Pharmaceuticals (INO) Reports 2014 Second Quarter Financial Results 8/11/2014
Telik, Inc. (TELK) Announces New Board Of Director Members To Oversee Reinvigorated Cancer Therapy Pipeline Resulting From The Recent Merger With MabVax Therapeutics, Inc. 8/11/2014
Akers Biosciences, Inc. Announces Conference Call To Discuss Its Second Quarter And Six Months Financial Results 8/11/2014
Geron Corporation (GERN) Reports Second Quarter 2014 Financial Results 8/11/2014
Rock Creek Pharmaceuticals Reports Second Quarter And Announces Clinical Update 8/11/2014
WaferGen Biosystems Reports Strong Revenue Growth For Q2 2014 8/8/2014
Bioheart, Inc. Releases Q2 Financial Information Showing Growth 8/8/2014
Amicus Therapeutics, Inc. (FOLD) Announces Second Quarter 2014 Financial Results And Corporate Updates 8/8/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Second Quarter 2014 Financial Results 8/8/2014
Receptos (RCPT) To Hold Second Quarter 2014 Financial Results Conference Call And Webcast 8/8/2014
Auspex Pharmaceuticals Reports Second Quarter 2014 Results 8/8/2014
Cara Therapeutics, Inc. (CARA) Reports Second Quarter 2014 Financial Results 8/8/2014
Minerva Neurosciences, Inc. (NERV) Reports Second Quarter 2014 Financial Results 8/8/2014
Aratana Therapeutics (PETX) To Report Second Quarter Financial Results 8/8/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Reports Financial Results For Second Quarter 2014 8/8/2014
XOMA (US) LLC (XOMA) Highlights Recent Achievements And Reports Financial Results For Second Quarter 2014 8/8/2014
Progenics Pharmaceuticals, Inc. (PGNX) Announces Second Quarter 2014 Financial Results 8/8/2014



//-->